Tango Therapeutics Inc
TNGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.37B
Close$
$-15.10
159% downside
Current Fair Value
159% downsideOvervalued by 159% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.37 Billion |
|---|---|
| Enterprise Value | $3.24 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.87 |
| Beta | 1.13 |
| Outstanding Shares | 143,576,292 |
Return
| Return on Equity | -27.39% |
|---|---|
| Return on Assets | -24.61% |
| Return on Invested Capital | -27.06% |
Valuation & Multiples
| P/E Ratio | -32.61 |
|---|---|
| PEG | -230.67 |
| Price to Sales | - |
| Price to Book Ratio | 12.79 |
| Enterprise Value to Revenue | 56.91 |
| Enterprise Value to EBIT | -28.44 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$1.56 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$3.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 98.66% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.17%▼ 139.00% |
|---|---|
| Total Invested | $725.84M▼ 80.76% |
| Investors Holding | 64▼ 134.00% |
ESG Score
No data
About Tango Therapeutics Inc
4 employees